Purification

Sapio Sciences Unveils Enhanced Molecular Biology Toolkit

Retrieved on: 
Martedì, Maggio 7, 2024

Sapio Sciences , the science-awareTM lab informatics platform, today announced Sapio ELN SM release 24.5.

Key Points: 
  • Sapio Sciences , the science-awareTM lab informatics platform, today announced Sapio ELN SM release 24.5.
  • Multimodal Entity Registration – Sapio’s enhanced molecular biology tools are integrated with small molecule research, enabling scientists to enhance their understanding and development of novel therapeutics.
  • “The rapid advances in molecular biology research require continual advances in the informatic tools scientists use to discover novel therapeutic products,” said Kevin Cramer, founder and CEO of Sapio Sciences.
  • The Sapio Platform provides a single, unified drug discovery platform that combines the Sapio ELN, Sapio LIMS ™, and Sapio Jarvis ™ to advance molecular biology research and foster innovative discoveries in biotechnology and pharmaceuticals.

Xtalks Announces its Life Science Webinar Calendar for January 2024

Retrieved on: 
Mercoledì, Gennaio 3, 2024

TORONTO, ON, Jan. 3, 2024 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Key Points: 
  • Upcoming free, educational webinars from Xtalks will feature topics on cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, human resources and career development, laboratory technology, medical device, pharmaceutical and pharma manufacturing & supply chain.
  • TORONTO, ON, Jan. 3, 2024 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries.
  • Access to all webinars is free, so be sure to register today to save your place!
  • Participate in the discussion and stay relevant in your field!

Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO

Retrieved on: 
Giovedì, Dicembre 21, 2023

Dr. Torchilin is succeeding David Wolf, who is retiring as President and CEO.

Key Points: 
  • Dr. Torchilin is succeeding David Wolf, who is retiring as President and CEO.
  • Dr. Torchilin will also join the Hamilton Thorne Board of Directors upon assuming the CEO role.
  • Hamilton Thorne Chairman David Wolf said: “We are delighted to welcome Kate as our new Chief Executive at this exciting time in our Company’s development.
  • He will also continue to work actively to develop acquisition initiatives and strategic stakeholder and industry relationships.

Global Downstream Processing Market Size, Share & Trends Analysis Report 2023: Chromatography Systems Segment Dominated in 2022 with 41.29% Market Share - Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Venerdì, Ottobre 27, 2023

The "Downstream Processing Market Size, Share & Trends Analysis Report By Product (Chromatography Systems, Filters), By Technique (Purification, Formulation), By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Downstream Processing Market Size, Share & Trends Analysis Report By Product (Chromatography Systems, Filters), By Technique (Purification, Formulation), By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global downstream processing market size is expected to reach USD 94.79 billion by 2030.
  • This expansion is set to unfold at an impressive compound annual growth rate (CAGR) of 14.84% from 2023 to 2030.
  • Notably, the surge in downstream processing techniques' adoption for COVID-19 vaccine development has played a pivotal role in propelling market growth.

Unlock the Secrets of Timeless Beauty and Harness the Power of Icelandic Kelp with TARAMAR's Purification Treatment

Retrieved on: 
Giovedì, Settembre 28, 2023

REYKJAVÍK, Iceland, Sept. 28, 2023 /PRNewswire/ -- TARAMAR, a pioneering force in skincare innovation, proudly unveils its latest breakthrough: the Purification Treatment.

Key Points: 
  • REYKJAVÍK, Iceland, Sept. 28, 2023 /PRNewswire/ -- TARAMAR, a pioneering force in skincare innovation, proudly unveils its latest breakthrough: the Purification Treatment.
  • This revolutionary skincare solution taps into the extraordinary rejuvenating properties of Icelandic kelp, a culmination of years of dedicated research and development by our expert team.
  • At its core, the Purification Treatment relies on NoTox®, an innovative technology devised by TARAMAR that extracts the potent skin rejuvenating properties of this oceanic wonder.
  • By combining these extracts with luxurious organic oils and a powerful skin-conditioning ester, TARAMAR's Purifying Treatment was born.

Unlock the Secrets of Timeless Beauty and Harness the Power of Icelandic Kelp with TARAMAR's Purification Treatment

Retrieved on: 
Giovedì, Settembre 28, 2023

REYKJAVÍK, Iceland, Sept. 28, 2023 /PRNewswire/ -- TARAMAR, a pioneering force in skincare innovation, proudly unveils its latest breakthrough: the Purification Treatment.

Key Points: 
  • REYKJAVÍK, Iceland, Sept. 28, 2023 /PRNewswire/ -- TARAMAR, a pioneering force in skincare innovation, proudly unveils its latest breakthrough: the Purification Treatment.
  • This revolutionary skincare solution taps into the extraordinary rejuvenating properties of Icelandic kelp, a culmination of years of dedicated research and development by our expert team.
  • At its core, the Purification Treatment relies on NoTox®, an innovative technology devised by TARAMAR that extracts the potent skin rejuvenating properties of this oceanic wonder.
  • By combining these extracts with luxurious organic oils and a powerful skin-conditioning ester, TARAMAR's Purifying Treatment was born.

MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing

Retrieved on: 
Mercoledì, Settembre 6, 2023

Mr. Soleymannezhad will lead global product development and marketing strategy for MaxCyte’s bioprocessing business.

Key Points: 
  • Mr. Soleymannezhad will lead global product development and marketing strategy for MaxCyte’s bioprocessing business.
  • “With his commercial background, strategic insight and demonstrated commitment to strong financial performance, Ali will be a great addition to our executive leadership team,” said Doug Doerfler, President and CEO of MaxCyte.
  • Most recently, he served as Executive Vice President for the Separations and Purification business at Tosoh Bioscience overseeing a team of 140 employees across four global manufacturing, development, and commercial sites.
  • During his tenure at Tosoh, Mr. Soleymannezhad was also Vice President of Global Marketing and Business Development and Director of Sales and Marketing Americas and served on the board of Semba Biosciences.

Chië -- Unveiling the Scent of Ancient Wisdom through Natural Incense

Retrieved on: 
Giovedì, Agosto 17, 2023

LOS ANGELES, Aug. 17, 2023 /PRNewswire/ -- Nippon Kodo introduces its newest incense line, Chië. Fragrant trees known as "Trees of God" have been around in different parts of the world since ancient times. These trees are often used during prayers and to purify the space, mind & body. This wisdom and practice continue to be cherished today. The meaning of this Buddhist terminology,"chië," is the ability to see things as they really are, recognizing the truth. Note the form of the "C" in the brand logo written in a Zen calligraphy style with a single stroke. It depicts a circle or "enso" which represents the infinite— the beginning and the end of everything, enlightenment, psychology, and the universe. Keeping true to ancient wisdom, Chië was designed for modern-day lifestyles, using no synthetic oils and no dyes, made only with natural aromatic ingredients.

Key Points: 
  • Connect with nature and release your mind with the brand-new collection of nine incense fragrances that reflect the ancient wisdom from all over the world to deliver serene luxury.
  • LOS ANGELES, Aug. 17, 2023 /PRNewswire/ -- Nippon Kodo introduces its newest incense line, Chië.
  • Fragrant trees known as "Trees of God" have been around in different parts of the world since ancient times.
  • Keeping true to ancient wisdom, Chië was designed for modern-day lifestyles, using no synthetic oils and no dyes, made only with natural aromatic ingredients.

Chart Industries Reports Record 2023 Second Quarter Financial Metrics

Retrieved on: 
Venerdì, Luglio 28, 2023

ATLANTA, July 28, 2023 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) today reported results for the second quarter ended June 30, 2023.

Key Points: 
  • ATLANTA, July 28, 2023 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) today reported results for the second quarter ended June 30, 2023.
  • Record second quarter 2023 financial metrics (backlog, orders, sales, gross profit, gross profit margin, operating income, and EBITDA).
  • Also in the second quarter 2023, Howden (on a standalone basis) had record reported backlog, orders, gross profit and EBITDA.
  • Second quarter 2023 backlog increased 24.1% compared to the second quarter 2022 (proforma to include Howden), and both Chart and Howden backlogs on a standalone basis were records as of the end of the second quarter 2023.

Global Genomics Market Report 2023: Sector is Expected to Reach $411.35 Billion by 2030 at a CAGR of 19.4% - ResearchAndMarkets.com

Retrieved on: 
Mercoledì, Luglio 12, 2023

The global genomics market size was valued at USD 27.81 billion in 2021 and is poised to grow from USD 33.25 billion in 2022 to USD 411.35 billion by 2030, growing at a CAGR of 19.4% in the forecast period (2023-2030).

Key Points: 
  • The global genomics market size was valued at USD 27.81 billion in 2021 and is poised to grow from USD 33.25 billion in 2022 to USD 411.35 billion by 2030, growing at a CAGR of 19.4% in the forecast period (2023-2030).
  • Government funding for genomics efforts has increased as a result of the rising incidence of cancer worldwide.
  • Global Genomics Market is segmented based on Deliverables, Technology, End Use, application, and Region.
  • The growth of Next-Generation Sequencing (NGS), which is increasingly being employed in cancer research, is driving the global genomics market.